Related references
Note: Only part of the references are listed.EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
Axel Heidenreich et al.
EUROPEAN UROLOGY (2011)
Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin
Tsutomu Kobayashi et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Overexpression of Galectin-3 and its clinical significance in ovarian carcinoma
Min Kyu Kim et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2011)
Galectin-3 Is a Substrate for Prostate Specific Antigen (PSA) in Human Seminal Plasma
Sarika Saraswati et al.
PROSTATE (2011)
Co-Purification of Mac-2 Binding Protein With Galectin-3 and Association With Prostasomes in Human Semen
Ashley S. Block et al.
PROSTATE (2011)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Galectin-3 expression is associated with bladder cancer progression and clinical outcome
Giacomo Canesin et al.
TUMOR BIOLOGY (2010)
Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential
S. Waalkes et al.
UROLOGE (2010)
Clinical significance of Galectin-3 in clear cell renal cell carcinoma
Manabu Sakaki et al.
JOURNAL OF MEDICAL INVESTIGATION (2010)
Evaluation of the prognostic significance of serum galectin-3 in American Joint Committee on Cancer stage III and stage IV melanoma patients
Pierre Vereecken et al.
MELANOMA RESEARCH (2009)
Tumor targeting and SPECT imaging properties of an 111In-labeled galectin-3 binding peptide in prostate carcinoma
Slisan L. Deutscher et al.
NUCLEAR MEDICINE AND BIOLOGY (2009)
Evidence of Heavy Methylation in the Galectin 3 Promoter in Early Stages of Prostate Adenocarcinoma: Development and Validation of a Methylated Marker for Early Diagnosis of Prostate Cancer
Hafiz Ahmed et al.
TRANSLATIONAL ONCOLOGY (2009)
The construction of high-density paraffin tissue microarrays with 0.43-mm-diameter paraffin tissue core biopsies is technically feasible
Ulrich F. Vogel
VIRCHOWS ARCHIV (2008)
Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survival
Axel S. Merseburger et al.
WORLD JOURNAL OF UROLOGY (2008)
Involvement of decreased galectin-3 expression in the pathogenesis and progression of prostate cancer
Axel S. Merseburger et al.
PROSTATE (2008)
Galectin-3 as a potential therapeutic target in tumors arising from malignant endothelia
Kim D. Johnson et al.
NEOPLASIA (2007)
Differential expression of galectins in normal, benign and malignant prostate epithelial cells: Silencing of galectin-3 expression in prostate cancer by its promoter methylation
Hafiz Ahmed et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Cathepsin D expression in renal cell cancer-clinical implications
AS Merseburger et al.
EUROPEAN UROLOGY (2005)
Effects of galectin-3 expression on growth and tumorigenicity of the prostate cancer cell line LNCaP
JA Ellerhorst et al.
PROSTATE (2002)
Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions
A Bartolazzi et al.
LANCET (2001)
Share Paper
